New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market November 26, 2024
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th November 1, 2024
Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease October 28, 2024
